A concurrent excitation and inhibition of dopaminergic subpopulations in response to nicotine

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Eddine, Raphaël ^a   Valverde, Sebastien ^a   Tolu, Stefania ^a   Dautan, Daniel ^a   Hay, Audrey ^a   Morel, Carole ^a   Cui, Yihui ^b   Lambolez, Bertrand ^a   Venance, Laurent ^b   Marti, Fabio ^a   Faure, Philippe ^a  

^a and Centre National de la Recherche Scientifique Unité Mixte de Recherche 8246   (France)

^b PSL RESEARCH UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR; NICOTINE;

ACTION POTENTIAL; ANIMAL; C57BL MOUSE; CHEMISTRY; DOPAMINERGIC NERVE CELL; DRUG EFFECTS; METABOLISM; MOUSE; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANIMALS; DOPAMINERGIC NEURONS; MICE; MICE, INBRED C57BL; NICOTINE; RECEPTORS, DOPAMINE D2; VENTRAL TEGMENTAL AREA;

EID: 84938542898     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08184     Document Type: Article

References (39)

1. Grenhoff, J., Aston-Jones, G. & Svensson, T. H. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128, 351-358 (1986).
2. Marti, F. et al. Smoke Extracts and Nicotine, but not Tobacco Extracts, Potentiate Firing and Burst Activity of Ventral Tegmental Area Dopaminergic Neurons in Mice. Neuropsychopharmacology 36, 2244-2257 (2011).
3. Maskos, U. et al. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436, 103-107 (2005).
4. Faure, P., Tolu, S., Valverde, S. & Naudé, J. Role of nicotinic acetylcholine receptors in regulating dopamine neuron activity. Neuroscience 282C, 86-100 (2014).
5. Di Chiara, G. & Imperato, A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 85, 5274-5278 (1988).
6. Lammel, S. et al. Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57, 760-773 (2008).
7. Lammel, S., Ion, D. I., Roeper, J. &Malenka, R. C. Projection-specific modulation of dopamine neuron synapses by aversive and rewarding stimuli. Neuron 70, 855-862 (2011).
8. Brischoux, F., Chakraborty, S., Brierley, D. I. & Ungless, M. A. Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli. Proc Natl Acad Sci USA 106, 4894-4899 (2009).
9. Lammel, S., Lim, B. K. &Malenka, R. C. Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 76 Pt B 351-359 (2014).
10. Bromberg-Martin, E. S., Matsumoto, M. & Hikosaka, O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 68, 815-834 (2010).
11. Mansvelder, H. D., Keath, J. R. & McGehee, D. S. Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33, 905-919 (2002).
12. Picciotto, M. R. et al. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391, 173-177 (1998).
13. Zhao-Shea, R. et al. Nicotine-mediated activation of dopaminergic neurons in distinct regions of the ventral tegmental area. Neuropsychopharmacology 36, 1021-1032 (2011).
14. Liu, L., Zhao-Shea, R., McIntosh, J. M., Gardner, P. D. & Tapper, A. R. 2012. Nicotine persistently activates ventral tegmental area dopaminergic neurons via nicotinic acetylcholine receptors containing a4 and a6 subunits. Mol Pharmacol 81, 541-548 (2012).
15. Mameli-Engvall, M. et al. Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors. Neuron 50, 911-921 (2006).
16. Li, W.,Doyon, W. M.&Dani, J. A. Acute in vivo nicotine administration enhances synchrony among dopamine neurons. Biochem Pharmacol 82, 977-983 (2011).
17. Erhardt, S., Schwieler, L. & Engberg, G. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine. Synapse 43, 227-237 (2002).
18. Ungless, M. A., Magill, P. J. & Bolam, J. P. Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303, 2040-2042 (2004).
19. Morel, C. et al. Nicotine consumption is regulated by a human polymorphism in dopamine neurons. Mol Psychiatry 19, 930-936 (2014).
20. Brown, M. T. C.,Henny, P., Bolam, J. P.&Magill, P. J. Activity of Neurochemically Heterogeneous Dopaminergic Neurons in the Substantia Nigra during Spontaneous and Driven Changes in Brain State. Journal of Neuroscience 29, 2915-2925 (2009).
21. Pinault, D. A novel single-cell staining procedure performed in vivo under electrophysiological control: morpho-functional features of juxtacellularly labeled thalamic cells and other central neurons with biocytin or Neurobiotin. J. Neurosci. Methods 65, 113-136 (1996).
22. Laviolette, S. R. & van der Kooy, D. Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Molecular Psychiatry 8, 50-9-9 (2003).
23. Beckstead, M. J., Grandy, D. K., Wickman, K. & Williams, J. T. Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42, 939-946 (2004).
24. Nair-Roberts, R. G. et al. Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience 152, 1024-1031 (2008).
25. Yamaguchi, T., Wang, H. L., Li, X., Ng, T. H. & Morales, M. Mesocorticolimbic Glutamatergic Pathway. Journal of Neuroscience 31, 8476-8490 (2011).
26. Hnasko, T. S., Hjelmstad, G. O., Fields, H. L. & Edwards, R. H. Ventral Tegmental Area Glutamate Neurons: Electrophysiological Properties and Projections. Journal of Neuroscience 32, 15076-15085 (2012).
27. Margolis, E. B., Coker, A. R., Driscoll, J. R., Lemaître, A.-I. & Fields, H. L. Reliability in the Identification of Midbrain Dopamine Neurons. PLoS ONE 5, e15222 (2010).
28. Ungless, M. A. & Grace, A. A. Are you or aren't you? Challenges associated with physiologically identifying dopamine neurons. TINS 35, 422-430 (2012).
29. Root, D. H. et al. Single rodent mesohabenular axons release glutamate and GABA. Nat Neurosci 17, 1543-1551 (2014).
30. Morales, M. & Root, D. H. Glutamate neurons within the midbrain dopamine regions. Neuroscience 282C, 60-68 (2014).
31. Li, X., Qi, J., Yamaguchi, T., Wang, H.-L. & Morales, M. Heterogeneous composition of dopamine neurons of the rat A10 region: molecular evidence for diverse signaling properties. Brain structure & function 218, 1159-1176 (2013).
32. Tolu, S. et al. Co-activation of VTA DA and GABA neurons mediates nicotine reinforcement. Mol Psychiatry 18, 382-393 (2013).
33. Ford, C. P., Phillips, P. E. M. & Williams, J. T. The time course of dopamine transmission in the ventral tegmental area. J Neurosci 29, 13344-13352 (2009).
34. Ford, C. P., Gantz, S. C., Phillips, P. E. M. &Williams, J. T. Control of extracellular dopamine at dendrite and axon terminals. Journal of Neuroscience 30, 6975-6983 (2010).
35. Fu, Y. et al. A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse. Brain structure & function (2011). doi:10.1007/s00429-011-0349-2
36. Ford, C. P. The role of D2-autoreceptors in regulating dopamine neuron activity and transmission. Neuroscience 282C, 13-22 (2014).
37. Chiodo, L. A., Bannon, M. J., Grace, A. A., Roth, R.H.&Bunney, B. S. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons. NSC 12, 1-16 (1984).
38. Margolis, E. B., Mitchell, J. M., Ishikawa, J., Hjelmstad, G. O. & Fields, H. L. Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition. Journal of Neuroscience 28, 8908-8913 (2008).
39. Bassareo, V., Tanda, G., Petromilli, P., Giua, C. & Di Chiara, G. Nonpsychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat. Psychopharmacology 124, 293-299 (1996).